Sotac Pharmaceuticals (SOTAC.NS) Stock Price

Sotac Pharmaceuticals Price

CLOSED
100.00INR+0.00 (+0.00 %)
Market closed

Over the last 5 years Sotac Pharmaceuticals grew revenue by 27.7% annually, reaching 969.87 M INR. Earnings per share have grown at 146.9% per year over the last 5 years. For Sotac Pharmaceuticals, the net margin of 8.3% is up versus -4.8% a few years ago. At today's price the dividend yield works out to roughly 0.10%. The payout ratio is around 1% of earnings.

Sotac Pharmaceuticals stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Sotac Pharmaceuticals over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Sotac Pharmaceuticals stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Sotac Pharmaceuticals's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Sotac Pharmaceuticals Stock Price History
DateSotac Pharmaceuticals Price
7/14/2026100.00 INR
7/13/2026100.00 INR
7/10/2026101.00 INR
7/9/2026101.00 INR
7/8/2026101.00 INR
7/7/2026101.00 INR
7/6/2026101.00 INR
7/3/2026105.00 INR
7/2/2026105.00 INR
7/1/2026105.00 INR
6/30/2026105.00 INR
6/29/2026105.00 INR
6/26/2026105.00 INR
6/25/2026105.00 INR
6/24/2026105.00 INR
6/23/2026105.45 INR
6/22/2026111.00 INR
6/19/2026111.00 INR
6/18/2026111.00 INR
6/17/2026111.00 INR
6/16/2026111.00 INR
6/15/2026111.00 INR
6/12/2026111.00 INR
6/11/2026111.00 INR
6/10/2026111.00 INR
6/9/2026111.00 INR
6/8/2026111.00 INR
6/5/2026111.00 INR
6/4/2026111.00 INR
6/3/2026111.00 INR
6/2/2026111.00 INR
6/1/2026111.00 INR
5/29/2026111.00 INR
5/28/2026111.00 INR
5/27/2026111.00 INR
5/26/2026111.00 INR
5/25/2026111.00 INR
5/22/2026111.30 INR
5/21/2026111.30 INR
5/20/2026111.30 INR
5/19/2026111.30 INR
5/18/2026111.30 INR
5/15/2026111.30 INR
5/14/2026111.30 INR
5/13/2026111.30 INR
5/12/2026111.30 INR
5/11/2026106.00 INR
5/8/2026106.00 INR
5/7/2026106.00 INR
5/6/2026106.00 INR
5/5/2026106.00 INR
5/4/2026111.15 INR
5/1/2026117.00 INR
4/30/2026117.00 INR
4/29/2026117.00 INR
4/28/2026117.00 INR
4/27/2026117.00 INR
4/24/2026117.00 INR
4/23/2026117.00 INR
4/22/2026117.00 INR
4/21/2026117.00 INR
4/20/2026117.00 INR
4/17/2026117.00 INR
4/16/2026112.00 INR
4/15/2026107.00 INR
4/13/2026102.00 INR
4/10/2026102.00 INR
4/9/2026101.25 INR
4/8/2026102.00 INR
4/7/2026102.00 INR
4/6/2026102.65 INR
4/2/2026108.00 INR
4/1/2026108.00 INR
3/30/2026109.25 INR
3/27/2026115.00 INR
3/25/2026115.00 INR
3/24/2026115.00 INR
3/23/2026115.00 INR
3/20/2026115.00 INR
3/19/2026115.00 INR
3/18/2026110.00 INR
3/17/2026110.55 INR
3/16/2026110.55 INR
3/13/2026110.55 INR
3/12/2026116.00 INR
3/11/2026111.00 INR
3/10/2026111.00 INR
3/9/2026111.00 INR
3/6/2026111.00 INR
3/5/2026111.00 INR
3/4/2026111.00 INR
3/2/2026111.00 INR
2/27/2026111.00 INR
2/26/2026111.00 INR
2/25/2026111.00 INR
2/24/2026115.00 INR
2/23/2026125.00 INR
2/20/2026125.00 INR
2/19/2026125.00 INR
2/18/2026125.00 INR
2/17/2026125.00 INR
2/16/2026125.00 INR
2/13/2026125.00 INR
2/12/2026125.00 INR
2/11/2026118.30 INR
2/10/2026118.30 INR
2/9/2026118.30 INR
2/6/2026118.30 INR
2/5/2026118.30 INR
2/4/2026118.30 INR
2/3/2026118.30 INR
2/2/2026118.30 INR
1/30/2026118.30 INR
1/29/2026112.90 INR
1/28/2026107.55 INR
1/27/2026107.55 INR
1/23/2026105.00 INR
1/22/2026100.00 INR
1/21/2026100.00 INR
1/20/2026100.00 INR
1/19/2026100.00 INR
1/16/2026100.00 INR
1/14/2026101.30 INR
1/13/2026112.10 INR
1/12/2026112.10 INR
1/9/2026112.10 INR
1/8/2026117.00 INR
1/7/2026123.10 INR
1/6/2026123.10 INR
1/5/2026123.10 INR
1/2/2026123.10 INR
1/1/2026123.10 INR
12/31/2025123.10 INR
12/30/2025129.55 INR
12/29/2025123.40 INR
12/26/2025123.40 INR
12/24/2025123.40 INR
12/23/2025123.40 INR
12/22/2025123.40 INR
12/19/2025123.40 INR
12/18/2025123.40 INR
12/17/2025123.40 INR
12/16/2025123.40 INR
12/15/2025123.40 INR
12/12/2025123.40 INR
12/11/2025129.55 INR
12/10/2025129.55 INR
12/9/2025129.55 INR
12/8/2025129.55 INR
12/5/2025129.55 INR
12/4/2025136.35 INR
12/3/2025139.65 INR
12/2/2025139.65 INR
12/1/2025138.50 INR
11/28/2025138.50 INR
11/27/2025133.00 INR
11/26/2025128.15 INR
11/25/2025122.55 INR
11/24/2025118.80 INR
11/21/2025125.00 INR
11/20/2025125.00 INR
11/19/2025122.55 INR
11/18/2025122.55 INR
11/17/2025122.55 INR
11/14/2025129.00 INR
11/13/2025129.00 INR
11/12/2025129.00 INR
11/11/2025129.00 INR
11/10/2025129.00 INR
11/7/2025129.00 INR
11/6/2025129.85 INR
11/4/2025129.85 INR
11/3/2025129.85 INR
10/31/2025129.85 INR
10/30/2025129.85 INR
10/29/2025125.00 INR
10/28/2025128.00 INR
10/27/2025128.50 INR
10/24/2025128.50 INR
10/23/2025128.50 INR
10/21/2025125.00 INR
10/20/2025125.00 INR
10/17/2025125.00 INR
10/16/2025125.00 INR
10/15/2025125.00 INR
10/14/2025125.00 INR
10/13/2025125.00 INR
10/10/2025125.00 INR
10/9/2025125.00 INR
10/8/2025119.15 INR
10/7/2025113.50 INR
10/6/2025108.10 INR
10/3/2025108.10 INR
10/1/2025108.10 INR
9/30/2025108.10 INR
9/29/2025113.75 INR
9/26/2025113.75 INR
9/25/2025113.75 INR
9/24/2025118.80 INR
9/23/2025124.40 INR
9/22/2025124.40 INR
9/19/2025124.40 INR
9/18/2025121.80 INR
9/17/2025122.50 INR
9/16/2025123.00 INR
9/15/2025123.00 INR
9/12/2025126.40 INR
9/11/2025126.40 INR
9/10/2025126.40 INR
9/9/2025125.00 INR
9/8/2025125.00 INR
9/5/2025125.10 INR
9/4/2025130.70 INR
9/3/2025130.70 INR
9/2/2025137.55 INR
9/1/2025137.55 INR
8/29/2025137.55 INR
8/28/2025137.55 INR
8/26/2025137.55 INR
8/25/2025137.55 INR
8/22/2025131.00 INR
8/21/2025131.00 INR
8/20/2025125.00 INR
8/19/2025125.00 INR
8/18/2025125.00 INR
8/14/2025125.00 INR
8/13/2025120.10 INR
8/12/2025126.05 INR
8/11/2025132.65 INR
8/8/2025130.85 INR
8/7/2025124.65 INR
8/6/2025118.75 INR
8/5/2025125.00 INR
8/4/2025125.00 INR
8/1/2025125.00 INR
7/31/2025125.00 INR
7/30/2025125.00 INR
7/29/2025123.95 INR
7/28/2025128.95 INR
7/25/2025125.00 INR
7/24/2025125.00 INR
7/23/2025124.00 INR
7/22/2025124.00 INR
7/21/2025124.00 INR
7/18/2025124.00 INR
7/17/2025129.85 INR
7/16/2025129.85 INR
Access this data via the Eulerpool API
Get Free API Key

Sotac Pharmaceuticals Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
286.04 M INR
4.62 M INR
875,000.00 INR
Jan 1, 2021
488.43 M INR
-11.39 M INR
-23.65 M INR
Jan 1, 2022
731.52 M INR
68.45 M INR
28.79 M INR
Jan 1, 2023
579.83 M INR
65.83 M INR
44.96 M INR
Jan 1, 2024
1.04 B INR
51.81 M INR
35.79 M INR
Jan 1, 2025
969.87 M INR
98.14 M INR
80.27 M INR

Sotac Pharmaceuticals Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 15, 2026, 1:21 PM
 
REVENUEB INR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM INR
NET INCOMEM INR
NET INCOME GROWTH%
DIV.INR
SHARESM
202020212022202320242025
0.290.490.730.581.040.97
–70.6349.80-20.7979.27-6.65
24.8319.2623.3930.9223.3129.51
71.0094.00171.00179.00242.00286.00
–-23.0028.0044.0035.0080.00
––-221.7457.14-20.45128.57
–––––0.10
11.0511.0511.0511.0511.0511.05
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Sotac Pharmaceuticals generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Sotac Pharmaceuticals retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Sotac Pharmaceuticals's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Sotac Pharmaceuticals has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Sotac Pharmaceuticals's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Sotac Pharmaceuticals stock margins

The Sotac Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sotac Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sotac Pharmaceuticals.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
25.09 %
1.61 %
0.31 %
Jan 1, 2021
19.35 %
-2.33 %
-4.84 %
Jan 1, 2022
23.48 %
9.36 %
3.94 %
Jan 1, 2023
30.90 %
11.35 %
7.75 %
Jan 1, 2024
23.33 %
4.99 %
3.45 %
Jan 1, 2025
29.57 %
10.12 %
8.28 %

Sotac Pharmaceuticals Stock Revenue, EBIT, Earnings per Share

The Sotac Pharmaceuticals earnings per share therefore indicates how much revenue Sotac Pharmaceuticals has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
25.89 INR
0.42 INR
0.08 INR
Jan 1, 2021
44.20 INR
-1.03 INR
-2.14 INR
Jan 1, 2022
66.20 INR
6.19 INR
2.61 INR
Jan 1, 2023
52.47 INR
5.96 INR
4.07 INR
Jan 1, 2024
93.96 INR
4.69 INR
3.24 INR
Jan 1, 2025
87.77 INR
8.88 INR
7.26 INR

Sotac Pharmaceuticals business model & stock analysis

Sotac Pharmaceuticals Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Sotac Pharmaceuticals historical P/E ratio, EBIT multiple, and P/S ratio

Sotac Pharmaceuticals annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Sotac Pharmaceuticals shares outstanding

The number of shares of Sotac Pharmaceuticals was 11.05 M in 2025. This indicates how many shares Sotac Pharmaceuticals is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
11.05 M Stocks
Jan 1, 2021
11.05 M Stocks
Jan 1, 2022
11.05 M Stocks
Jan 1, 2023
11.05 M Stocks
Jan 1, 2024
11.05 M Stocks
Jan 1, 2025
11.05 M Stocks

Sotac Pharmaceuticals Dividend History

1 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.10INR—1×
Sep 19, 20250.10INR—1/1

Sotac Pharmaceuticals dividend history and estimates

In 2025, Sotac Pharmaceuticals paid a dividend amounting to 0.10 INR. Dividend means that Sotac Pharmaceuticals distributes a portion of its profits to its owners.

  • Max

Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2025 (e)
0.00 INR
0.10 INR

Sotac Pharmaceuticals dividend payout ratio

In 2025, Sotac Pharmaceuticals had a payout ratio of 1.38%. The payout ratio indicates the percentage of the company's profits that Sotac Pharmaceuticals distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
1.38 %
Jan 1, 2021
1.38 %
Jan 1, 2022
1.38 %
Jan 1, 2023
1.38 %
Jan 1, 2024
1.38 %
Jan 1, 2025
1.38 %
Price targets and forecasts for Sotac Pharmaceuticals are not yet available.

Sotac Pharmaceuticals Executives and Management Board

SP

Mr. Sharadkumar Patel

(43)

Managing Director, Executive Chairman · since 2022

Compensation1.80 M INR
DG

Mr. Dineshkumar Gelot

(40)

Whole Time Director · since 2022

Compensation1.80 M INR
BP

Mr. Brijeshkumar Patel

Chief Financial Officer

Compensation490,000.00 INR
PM

Mr. Pankaj Mahabaleshwarkar

Chief Operating Officer

NP

Ms. Niyati Parikh

Chief Compliance Officer, Company Secretary

Frequently asked questions about Sotac Pharmaceuticals

Converted at the current exchange rate, the Sotac Pharmaceuticals share trades at 0.91 EUR (100.00 INR).

All fundamentals and in-depth analysis of Sotac Pharmaceuticals

Our stock analysis for Sotac Pharmaceuticals stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sotac Pharmaceuticals. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals Revenue→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals Net Income→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals P/E→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals P/S→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals EBIT→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals Dividend→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals Directors Dealings→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals Stocks→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals Market capitalization→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals Debt→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals Liabilities→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals Equity→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals AAQS→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals Employees→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals ROE→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals ROA→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals ROCE→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals News→
Sotac Pharmaceuticals Stock
Sotac Pharmaceuticals Analyst Price Targets→

Health Stocks

Sotera HealthSorrento TherapeuticsSource Natural Foods and Herbal SupplementsSOPHiA GENETICSSpago Nanomedical AB (publ)Sonova HoldingSpecialized Medical Company SCJSCSonoScape MedicalSpectraCure AB (publ)Sonoma PharmaceuticalsSpectral AISonida Senior LivingAll Stocks A–Z →